share_log

丽珠医药(01513.HK):截至2月29日累计回购247.63万股H股

Livzon Pharmaceuticals (01513.HK): As of February 29, a total of 2.4763 million H shares have been repurchased

Gelonghui Finance ·  Mar 4 04:11

On March 4, GLONGHUI Pharmaceutical (01513.HK) announced that as of February 29, 2024, the company had repurchased a total of 2,476,300 shares of the company's H shares, accounting for 0.27% of the company's total share capital. The highest purchase price was HK$25.15 per share, the lowest price was HK$23.05 per share, and the total amount of capital used was HK$60363.26 million (excluding transaction fees).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment